Rise Nano Optics Ltd. News Releases

Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices

Thu, 24 Sep 2026 07:00:00 -0400

Company to participate in curated one-on-one meetings with leading independent optometry practice owners as it expands U.S. commercialization of SpectraGuard(TM) Vancouver, British Columbia--(Newsfile Corp. - September 24, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that it will participate as a sponsor of INVISION MATCH! 2026, an...

Rise Nano Optics to Attend the Vision Council's 2026 Lab Leadership Forum

Wed, 16 Sep 2026 07:00:00 -0400

Sold-out industry forum brings together leaders from the independent optical laboratory sector as Rise advances its lab-first commercialization strategy for SpectraGuard™Vancouver, British Columbia--(Newsfile Corp. - September 16, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that the Company will attend The Vision Council's 2026 Lab...

Rise Nano Optics Joins the Vision Council, a Leading Optical Trade Association, Expanding Access to Key Optical Relationship

Thu, 20 Aug 2026 03:00:00 -0400

Membership provides access to hundreds of optical manufacturers, laboratories, retailers and industry stakeholders as Rise accelerates North American commercialization of its patented SPECTRAGUARD(TM) lens technology Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, is pleased to announce that it...

Rise Nano Optics Announces Frankfurt Stock Exchange Listing

Mon, 10 Aug 2026 07:00:00 -0400

Expanding European investor access and global visibility for patented SPECTRAGUARD™ technologyVancouver, British Columbia--(Newsfile Corp. - August 10, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, is pleased to announce that its common shares are now listed and trading on the Frankfurt Stock Exchange under the trading symbol "U9Y"The Frankfurt Stock...

Rise Nano Optics Ltd. Announces AGSM Results

Thu, 06 Aug 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) ("Rise" or the "Company"), is pleased to announce that all resolutions were passed at the annual general and special meeting of shareholders (the "AGSM") held yesterday in person at 10:00 am (Pacific Time).Annual General and Special Meeting ResultsA total of 16,027,785 common shares in the capital of the Company ("Common Shares") were represented at the AGSM, representing 39.35% of...

Rise Nano Optics Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. Investors

Tue, 04 Aug 2026 07:00:00 -0400

Commenced Trading on the OTCQB Under the Symbol "RNOLF" While Continuing to Trade on the CSE Under the Symbol "EYE" Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) ("Rise" or the "Company") a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that its common shares have been approved to commence trading on the OTCQB Venture Market, operated by OTC Markets Group Inc. The...

Rise Nano Optics Announces First U.S. Eye Care Professional Partnership with LI Opticians

Thu, 09 Jul 2026 00:15:00 -0400

First Clinical Channel Partnership in the United States as Part of the Company's Phased Commercialization Strategy Vancouver, British Columbia--(Newsfile Corp. - July 9, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced its first U.S. eye care professional (ECP) partnership with LI Opticians, an independent optical practice located in Seaford, New York, owned and...

Rise Nano Optics Announces Strategic Partnership with SportifEye Optics to Produce and Commercialize SpectraGuard(TM) Lenses in the United States

Wed, 24 Jun 2026 00:15:00 -0400

Expanding Lab Partnership Network now includes expertise in Sport, Safety and Performance Eyewear Vancouver, British Columbia--(Newsfile Corp. - June 24, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced a strategic partnership with SportifEye Optics ("SportifEye"), a cutting-edge, full-service optical laboratory and VSP®-Authorized Lab based in Southern California,...

Rise Nano Optics Announces Strategic Partnership with Sierra Optical Lab to Produce and Commercialize SpectraGuard(TM) Lenses in the United States

Mon, 20 Apr 2026 07:00:00 -0400

Significant Milestone in Defined North American Commercialization Strategy Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced a strategic partnership with Sierra Optical Lab ("Sierra Optical"), an independent wholesale optical laboratory and VSP®-Authorized Lab, located in Reno, Nevada, to support the...

Rise Nano Optics Announces FDA Class I Device Classification for SPECTRAGUARD(TM) Nano-Optic Lens Technology

Mon, 23 Mar 2026 07:00:00 -0400

Proprietary, patented technology providing vision protection beyond UV and Blue Light Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company") a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that its proprietary, patented SPECTRAGUARD™ nano-optic lens technology is FDA registered and has been classified by the U.S. Food and Drug Administration (FDA) as a Class I...